Imexpharm Corporation announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was VND 317,424.000 million compared to VND 288,702.000 million a year ago. Operating income was VND 60,004.354 million compared to VND 56,613.154 million a year ago. Net income was VND 49,324.501 million compared to VND 47,311.395 million a year ago. Basic earnings per share from continuing operations was VND 651 compared to VND 648 a year ago. For the half year, total revenue was VND 613,861.000 million compared to VND 592,389.000 million a year ago. Operating income was VND 112,698.000 million compared to VND 107,957.000 million a year ago. Net income was VND 91,179.995 million compared to VND 88,425.606 million a year ago. Basic earnings per share from continuing operations was VND 1,266 compared to VND 1,212 a year ago.